Last updated on April 18, 2014 at 10:59 EDT

Popper and Company Announces Stephanie Kreml, M.D., As Newest Team Member

April 3, 2013

- As Practicing Physician with Engineering Background, Dr. Kreml Brings Unique Multi-Disciplinary Perspective to Helping Life Sciences Companies Address Complex Business Challenges -

BALTIMORE and AUSTIN, Texas, April 3, 2013 /PRNewswire/ — Popper and Company, an M&A advisory and specialty consulting firm to the life sciences industry, announced today that Stephanie Kreml, M.D. has returned to the firm as Principal. Dr. Kreml, who previously worked at Popper and Company from 2008 to 2010, has a broad career spanning clinical research, product engineering, medical technologies, and commercialization strategy roles.

“We are thrilled to welcome back Stephanie to Popper and Company,” said Caroline Popper, M.D., M.P.H., the firm’s Co-founder and President. “Stephanie’s medical background (she is a practicing physician) and technical know-how as a trained engineer will be a tremendous asset to Popper and Company’s clients.” Currently the firm has locations in Florida, Baltimore/Washington, DC, Albuquerque, Toronto and Austin, and serves clients worldwide ­- primarily in the diagnostics, device and digital health space.

In her role as Principal, Dr. Kreml will develop and implement business strategy for start-up companies and new business units in existing companies; consult in areas of clinical need, commercialization, and technology assessment; perform due diligence for investment and acquisition targets in the life science industry; critically evaluate unmet clinical needs and technologies; and provide guidance to accelerate new production development activities.

“After practicing medicine for the last few years, I return to Popper and Company with a renewed vigor and excitement to pursue the intellectual challenges of our assignments as we deliver results for our clients,” said Dr. Kreml. “With the rapid convergence of technology and medicine – and the rise of digital health as an industry in its own rite – I can leverage my unique perspective as a physician and an engineer to help life science companies better address diverse healthcare issues.”

From 2010 to 2013, Dr. Kreml held the positions of Associate Medical Director and Center Medical Director at Concentra in Austin, Texas, and she continues to practice as a staff physician part-time. Prior to medical school, she held engineering positions with Motorola and Texas Instruments.

Dr. Kreml received her Doctor of Medicine from the Baylor College of Medicine and a Bachelor of Science in Electrical Engineering from The University of Texas at Austin. During her residency in general surgery, she was a research fellow at Baylor College of Medicine’s Human Genome Sequencing Center and in the Mechatronics and Haptic Interfaces Lab at Rice University.

About Popper and Co.
Founded in 2003, Popper and Company is an M&A advisory and specialty consulting firm whose mission is to help clients across the life sciences spectrum – from public companies to private companies to investors – address complex challenges, providing clients with unparalleled attention and, through the deep domain expertise of its principals, creative and insightful advice. The firm’s operational background spans clinical, technology, marketing and finance in a variety of capacities in the diagnostics, medical device and pharmaceutical industries. The Popper and Company team delivers perspective, value, and high-quality, hands-on service in the areas of business development, mergers and acquisitions, strategic development, product development, and diligence. Visit www.popperandco.com for more information.

SOURCE Popper and Co.

Source: PR Newswire